Gilead and Novo Nordisk have announced their drug combinations for the fatty liver disease known as NASH checked out in a mid-stage proof-of-concept study. The companies said the trial met its primary ...
Abstract: Multichannel acoustic signal processing is a well-established and powerful tool to exploit the spatial diversity between a target signal and nontarget or noise sources for signal enhancement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback